SecBot SecBot

BZYR

BURZYNSKI RESEARCH INSTITUTE INC
OTC· In Vitro & In Vivo Diagnostic Substances· Inc. DE· CIK 0000724445 Biotech & Drug Discovery
$0.000200 +0.00 (+0.00%)
Oct 26 4:00 PM ET · prev $0.000200
Next earnings
Nov 6
in 10 days
Since first trade
−99.0%
from $0.0200 · Jan 2
30 days
−89.7%
from $0.001950
Range since listing
$0.000200–0.0380
−99% from high · low Oct 2
Avg volume 20D
542
Oct 12 spike 10.0K
Filing reports
1
analyzed by SecBot
SecBot read MIXED 1 report · latest
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 6, 2026
Strongest NEUTRAL Patryk P. Goscianski resigned as CFO and Secretary of Burzynski Research Institute, Inc. effective April 17…
All reports →

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • TrendDOWNTREND

    92% below its 50-day average. New closing low $0.000200 on Oct 26.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 6, 2026
Earnings date
BZYR Q2 2027 Earnings Scheduled — 2026-11-06
Recent
Oct 12, 2026
Earnings date
BZYR Q2 2027 Earnings Scheduled — 2026-10-12
Aug 28, 2026
Earnings date
BZYR Q1 2027 Earnings Scheduled — 2026-08-28
Aug 11, 2026
Earnings date
BZYR Q1 2027 Earnings Scheduled — 2026-08-11
Jul 16, 2026
Earnings date
BZYR Q1 2027 Earnings Scheduled — 2026-07-16
Jul 13, 2026
Earnings date
BZYR Q1 2027 Earnings Scheduled — 2026-07-13

Earnings setup

Estimates
Nov 6
reports in 10 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 12, 2026 Earnings calendar
BZYR Q2 2027 Earnings Scheduled — 2026-10-12
Apr 23, 2026 SEC
Patryk P. Goscianski resigned as CFO and Secretary of Burzynski Research Institute, Inc. effective April 17, 2026, due…
8-K — Impact 3/10

SecBot reports

1 filing · 0 bullish · 0 bearish · 1 neutral
All BZYR filing & press-release reports (1)